We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

75 hedge funds and large institutions have $143M invested in Immunomedics Inc in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

1% less capital invested

Capital invested by funds: $146M → $143M (-$2.03M)

7% less funds holding

Funds holding: 8175 (-6)

34% less call options, than puts

Call options by funds: $4.33M | Put options by funds: $6.57M

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
75
Holders Change
-6
Holders Change %
-7.41%
% of All Funds
2.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
27
Reduced
18
Closed
14
Calls
$4.33M
Puts
$6.57M
Net Calls
-$2.25M
Net Calls Change
-$1.71M

IMMU Hedge Fund Activity: Q1 2014 in Review

75 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2014, worth a combined $143M — down 1.4% from $146M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IMMU and 8 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $13M. The largest seller was SAC Capital Advisors, exiting entirely with an estimated $6.43M sold.

  • 75 institutional investors held Immunomedics Inc (IMMU) as of Q1 2014, down from 81 in Q4 2013.
  • Funds reported $143M of Immunomedics Inc stock for Q1 2014, down 1.4% quarter-over-quarter.
  • 8 funds opened new Immunomedics Inc positions in Q1 2014 and 14 closed out, a net change of -6 holders.
  • The largest Immunomedics Inc buyer in Q1 2014 was Deerfield Management, an estimated $13M added.
  • The largest Immunomedics Inc seller in Q1 2014 was SAC Capital Advisors, an estimated $6.43M sold.

Based on aggregated 13F filings for Q1 2014.